For a small company quoted on the OTC markets, few things arrive with less warning than a promotion flag. One morning the stock’s quote page on otcmarkets.com carries a new designation — “Promotion” — and by mid-session the phone is ringing. Brokers are declining to open positions. A market maker has widened the spread. Shareholders want to know what the company did wrong.
Often the answer is: nothing. The flag is not an accusation. But it is a real constraint, and understanding how it works is the difference between clearing it in a few weeks and watching it harden into something considerably worse.
What the flag actually is
OTC Markets Group operates the quotation systems where most non-exchange-listed U.S. equities trade. It is not a regulator — it cannot bring an enforcement action or suspend trading the way the SEC can — but it controls what information appears alongside a security’s quote, and that turns out to be a substantial form of leverage.
Under its stock promotion policy, OTC Markets monitors for paid promotional campaigns: mailers, email blasts, promotional newsletters and websites, sponsored social media, and paid stock-picking services. When its compliance team identifies a campaign targeting a security, it applies a promotional activity designation to that security’s profile.
The flag communicates a single fact: someone is being paid to generate buying interest in this stock. It does not assert that the issuer paid, that the promotion is fraudulent, or that the company’s disclosures are inaccurate. Third-party promotion is common precisely because it can be launched by anyone — a shareholder with a large position, a convertible noteholder looking for exit liquidity, a promoter operating on spec. The issuer frequently learns about the campaign from the flag itself.
The flag is also distinct from Caveat Emptor, the skull-and-crossbones designation OTC Markets applies to securities where it has public-interest concerns. Caveat Emptor is far more damaging: it removes the security from public quoting on OTC Link, and in practice pushes it toward the Expert Market, where retail investors generally cannot buy at all. The relationship between the two matters enormously, because an unaddressed promotion flag is one of the more reliable paths to a Caveat Emptor designation.
Why the flag is hard to simply argue away
Issuers often approach this as a public relations problem and try to talk their way out. That reliably fails, for a structural reason worth understanding.
The economic engine behind a promotional campaign is almost always cheap stock. Someone holds shares at a cost basis far below market — from a reverse merger into a shell, from an S-1 registration, from conversion of a toxic note at a steep discount to market. The campaign creates volume and price appreciation. The holder sells into it. The buyers during the campaign supply the profit.
OTC Markets knows this pattern well, and its questions are shaped by it. Its compliance team is not asking whether the company is a good business. It is asking whether anyone connected to the company benefited from the campaign, and whether the share structure permits the kind of dilution that makes campaigns profitable. A well-produced investor deck does not answer either question.
The removal path
OTC Markets publishes its promotion policy, and its issuer compliance team will state its specific requirements to a flagged issuer directly. I would encourage any company in this position to work from those primary sources. What follows is the general shape of the process as it has operated.
- Respond to the compliance inquiry promptly and completely. OTC Markets typically contacts the flagged issuer with a set of questions about the promotional activity. Silence is read as consent to the worst interpretation, and non-responsiveness is itself grounds for escalation. This is the single most common unforced error.
- Publicly disclose what you know, through the right channel. The expected response is a public statement — issued through OTC Markets’ Disclosure & News Service or, for SEC reporting companies, through the appropriate filing — that addresses the campaign directly. A useful disclosure states whether the company or anyone acting on its behalf paid for or authorized the promotion; whether officers, directors, control persons, or affiliates sold shares during the campaign; who the company believes funded it, if known; and that the company disclaims the promotional materials and their contents. Vague statements distancing the company in general terms are not effective. Specific denials of specific facts are.
- Investigate your own perimeter before you deny anything. Companies have issued flat denials and then discovered that an investor relations firm they retained had subcontracted to a promoter, or that a consultant paid in shares had funded a campaign to create an exit. A denial that turns out to be false is substantially worse than the flag. Check IR agreements, consulting contracts, and any arrangement where someone was compensated in stock.
- Address the share structure if it is the underlying problem. Where a company has convertible notes outstanding at a discount to market, or a large authorized-but-unissued share count, OTC Markets may treat the promotion as a symptom rather than an isolated event. Retiring toxic debt, reducing the authorized count, or imposing lock-ups on insider holdings are the kinds of changes that address the actual concern.
- Then wait. The designation is not lifted the moment a press release goes out. It remains displayed while the campaign is active and for a period after it concludes, so investors reviewing the stock during and shortly after the promotion see the warning. I am not confident of the exact duration currently applied and would not want a company planning around a number I’ve stated from memory — confirm it with OTC Markets directly.
When there is no removal path
Some situations do not resolve. If the company or its insiders funded the campaign, or sold into it, the issue is no longer a warning label. That conduct implicates Section 17(b) of the Securities Act, which requires anyone touting a security for consideration to disclose who paid them and how much, and it can implicate the antifraud provisions more broadly. OTC Markets will escalate, and the company will likely have a larger problem than a designation on a quote page. Counsel, not communications strategy, is the appropriate response.
It is also worth saying plainly: the flag exists to protect the people buying the stock. An issuer’s interest in removing it and an investor’s interest in seeing it are not automatically aligned. The removal process is designed so that the designation comes off when the underlying facts warrant — when the company genuinely had no involvement, has said so specifically and publicly, and the campaign has run its course. A company approaching this as a matter of getting a warning label deleted is likely to find the process frustrating. A company approaching it as a matter of establishing a clear public record of what happened will generally find it navigable.
This article is general information, not legal or financial advice. Securities counsel with OTC market experience is worth retaining early in this process — the disclosure decisions made in the first week tend to constrain the options available later.
To speak with a Securities Attorney, please contact Brenda Hamilton at 200 E Palmetto Rd, Suite 103, Boca Raton, Florida, (561) 416-8956, or by email at [email protected].
Hamilton & Associates | Securities Attorneys
Brenda Hamilton, Securities Attorney
200 E Palmetto Rd, Suite 103
Boca Raton, Florida 33432
Telephone: (561) 416-8956
Facsimile: (561) 416-2855
www.SecuritiesLawyer101.com